scispace - formally typeset
M

Mark Gelfand

Researcher at Johns Hopkins University

Publications -  153
Citations -  9789

Mark Gelfand is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Neuromodulation (medicine) & Heart failure. The author has an hindex of 50, co-authored 153 publications receiving 9785 citations.

Papers
More filters
Patent

Methods and apparatus for renal neuromodulation

TL;DR: In this article, a pulsed electric field was used to induce electroporation or electrofusion of percutaneous intravascular vessels to reduce expansion of an acute myocardial infarction, reduce or prevent the onset of morphological changes that are affiliated with congestive heart failure, and/or be efficacious in the treatment of end stage renal disease.
Patent

Renal nerve stimulation method and apparatus for treatment of patients

TL;DR: A method and apparatus for treatment of heart failure, hypertension and renal failure by stimulating the renal nerve is described in this paper, where the goal is to reduce the sympathetic activity of renal nerve.
Patent

Methods and systems for thermally-induced renal neuromodulation

TL;DR: In this article, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy, in which parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors for controlling the thermallyinduced neuromodi modality.
Patent

Methods and apparatus for thermally-induced renal neuromodulation

TL;DR: In this article, thermally-induced renal neuromodulation is achieved via delivery of a pulsed thermal therapy, where the parameters of the neural fibers, of non-target tissue, or of the thermal energy delivery element, may be monitored via one or more sensors.
Patent

Methods and devices for renal nerve blocking

TL;DR: In this paper, a method and apparatus for treatment of cardiac and renal diseases associated with the elevated sympathetic renal nerve activity by implanting a device to block the renal nerve signals to and from the kidney.